摘要
目的总结腹部单中心型Castleman病患者的临床特点,提高外科医师对该疾病诊断、治疗及预后的认识。方法回顾性分析2019年10月至2022年10月就诊于河北医科大学第二医院的行手术治疗的腹部单中心型Castleman病8例患者的临床资料,总结患者的影像学特征、病理类型及预后。结果本组8例患者中男2例,女6例,平均就诊年龄为(33.0±13.7)岁,平均BMI(23.2±4.5)kg/m^(2),肿物中位最大直径为4.5(3.0~4.9)cm,术后中位住院时间为6.5(3.3~12.0)d。除1例患者失访外,其余7例患者在术后随访中无复发及其他术后并发症的发生。结论腹部单中心型Castleman病较为罕见。完整切除肿物是腹部单中心型Castleman患者的主要治疗方式,预后良好。
Objective To summarize the clinical characteristics of patients with unicentric Castleman disease(UCD).Method The clinical data of 8 abdominal UCD patients who received surgical resection at the Second Hospital of Hebei Medical University from Oct 2019 to Oct 2022 were analyzed,and the imaging characteristics,pathological types and prognosis were summarized.Result There were 2 males and 6 females.The average age of patients was(33.0±13.7)years old,and their BMI was(23.2±4.5)kg/m^(2).The median maximum diameter of the tumor was 4.5(3.0-4.9)cm.The average postoperative hospital stay was 6.5(3.3-12.0)days.One was lost during follow up,there was no recurrence or other postoperative complications in the remaining 7 patients.Conclusion The incidence of unicentric Castleman disease is rare.Complete resection of the tumor is the main treatment for UCD patients,and the prognosis of UCD is good.
作者
杨昕达
李冬瑞
杜成旭
张腾飞
李召
李默涵
吕海涛
Yang Xinda;Li Dongrui;Du Chengxu;Zhang Tengfei;Li Zhao;Li Mohan;Lyu Haitao(Department of Hepatobiliary Surgery,The Second Hospital of Hebei Medical University,Shijiazhuang 050000,China)
出处
《中华普通外科杂志》
CSCD
北大核心
2023年第7期526-529,共4页
Chinese Journal of General Surgery